DONIDALORSEN (Dawnzera®)
Clinical Indication
for preventing recurrent attacks of hereditary angioedema in people 12 years and over
Date of classification
September 2026
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.